The dopaminergic system has been the main focus for almost 70 years and dopaminergic-based strategies still remain the best symptomatic medication to improve quality of life of parkinsonian patients.
Excepto si se señala otra cosa, la licencia del ítem se describe como This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)